Skip to main content
. 2021 Jun 4;100(22):e26167. doi: 10.1097/MD.0000000000026167

Table 2.

Surgical information and pathological characteristics of patients with pancreatic head cancer.

D Group V Group
Characteristics n = 42 n = 59 P value
Surgical information
 Standard lymphadenectomy 27 (64.3%) 34 (57.6%) .500
 Extended lymphadenectomy 15 (35.7%) 25 (42.4%) .500
 Blood lose, mL 650 (200–2100) 730 (200–2250) .887
 Blood transfusion 7 (16.7%) 12 (20.3%) .642
 Postoperative complications 12 (28.6%) 18 (30.5%) .461
 Positive surgical margin 3 (7.1%) 2 (3.4%) .647
 Postoperative chemotherapy 15 (35,7%) 19 (32.2%) .713
Tumor factors
 Tumor size, cm 3.15 ± 0.83 2.72 ± 0.66 .005
 Vascular invasion positive 14 (33.3%) 22 (37.3%) .683
 Perineural invasion positive 37 (88.1%) 52 (88.1%) .995
 Lymph node invasion positive 24 (57.1%) 31 (52.5%) .647
 LN8, LN12 invasion positive 19 (45.2%) 6 (10.2%) .001
 LN14 invasion positive 2 (4.8%) 19 (32.2%) .002
 LN16 invasion positive 12 (28.6%) 13 (22.0%) .453
 Bile duct invasion positive 33 (78.6%) 35 (59.3%) .042
 Duodenal invasion positive 30 (71.4%) 26 (44.1%) .006
 Serosal infiltration positive 28 (66.7%) 47 (79.7%) .141
Pathological UICC stage .504
 Ia 2 (4.8%) 1 (1.7%)
 Ib 12 (28.6%) 25 (42.4%)
 IIa 3 (7.1%) 2 (3.4%)
 IIb 15 (35.7%) 21 (35.6%)
 III 10 (23.8%) 10 (16.9%)